ClinicalTrials.Veeva

Menu

Influence of Resentment and Forgivingness on Quality of Life in People Living With HIV (FORGHIV)

C

Centre Hospitalier Universitaire, Amiens

Status

Enrolling

Conditions

Health
Stigma
Hiv
Forgiveness
Stress

Study type

Observational

Funder types

Other

Identifiers

NCT05660148
PI2022_843_0010

Details and patient eligibility

About

Life stress is strongly associated with poor mental and physical health and its effects explain significant morbidity and mortality. Forgiveness is one of the factors that can influence the effects of stress on health. By definition, forgiveness is the release of negative feelings, emotions, and behaviors - and possibly the release of positive feelings - toward an offender. Numerous studies have shown that forgiveness is associated with several mental and physical health benefits. The literature argues that high levels of propensity to forgive (trait) predispose that person to experience forgiveness (state) more often. In other words, a stronger forgiving disposition is believed to increase the experience of forgiveness, which, in turn, mitigates the negative effects of stress. Forgiveness is therefore a coping style that can play a beneficial role in the stress-health relationship. Patients living with HIV (PLHIV) are patients particularly exposed to stress, not only because of their chronic pathology but also because of the stigma attached to this disease. Very few studies have studied the impact of forgiveness (state or trait) on the physical health of PLHIV and even fewer the impact of an intervention promoting the disposition to forgive. The objective of this prospective observational monocentric study is to show in a very secular country that forgiveness has an effect on well-being as well as on other health parameters.

Enrollment

206 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Belonging to the PLHIV followed at the Amiens University Hospital, not likely to move within the year
  • Possibility of follow-up in teleconsultation (usual support of the service)
  • Benefiting from a social security scheme
  • Consent to participate in the research

Exclusion criteria

  • Erratic follow-up (non-compliance, predictable move) or moribund patient
  • Illiterate or not speaking french

Trial contacts and locations

1

Loading...

Central trial contact

Jean-Philippe Lanoix, Pr

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems